Granahan Investment Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.51M | Buy |
240,038
+56,230
| +31% | +$1.76M | 0.31% | 81 |
|
|
2025
Q1 | $6.17M | Buy |
183,808
+1,475
| +0.8% | +$49.5K | 0.31% | 86 |
|
|
2024
Q4 | $7.15M | Sell |
182,333
-18,544
| -9% | -$727K | 0.3% | 86 |
|
|
2024
Q3 | $7.91M | Sell |
200,877
-25,289
| -11% | -$996K | 0.31% | 97 |
|
|
2024
Q2 | $8.82M | Sell |
226,166
-17,914
| -7% | -$698K | 0.35% | 87 |
|
|
2024
Q1 | $10.5M | Sell |
244,080
-58,501
| -19% | -$2.52M | 0.37% | 81 |
|
|
2023
Q4 | $13.9M | Buy |
302,581
+66,291
| +28% | +$3.05M | 0.46% | 70 |
|
|
2023
Q3 | $8.07M | Sell |
236,290
-463
| -0.2% | -$15.8K | 0.29% | 100 |
|
|
2023
Q2 | $9.11M | Sell |
236,753
-39,259
| -14% | -$1.51M | 0.28% | 95 |
|
|
2023
Q1 | $9.88M | Sell |
276,012
-48,238
| -15% | -$1.73M | 0.3% | 91 |
|
|
2022
Q4 | $12.8M | Buy |
324,250
+24,395
| +8% | +$962K | 0.39% | 72 |
|
|
2022
Q3 | $10.8M | Buy |
299,855
+15,083
| +5% | +$545K | 0.35% | 86 |
|
|
2022
Q2 | $8.66M | Buy |
284,772
+22,067
| +8% | +$671K | 0.3% | 89 |
|
|
2022
Q1 | $8.03M | Buy |
262,705
+45,404
| +21% | +$1.39M | 0.2% | 105 |
|
|
2021
Q4 | $6.79M | Buy |
217,301
+133,447
| +159% | +$4.17M | 0.14% | 134 |
|
|
2021
Q3 | $1.28M | Buy |
83,854
+605
| +0.7% | +$9.24K | 0.02% | 184 |
|
|
2021
Q2 | $1.55M | Buy |
83,249
+161
| +0.2% | +$3K | 0.03% | 182 |
|
|
2021
Q1 | $1.49M | Sell |
83,088
-70,233
| -46% | -$1.26M | 0.03% | 177 |
|
|
2020
Q4 | $2.36M | Sell |
153,321
-5,383
| -3% | -$82.8K | 0.05% | 171 |
|
|
2020
Q3 | $1.76M | Buy |
158,704
+47,705
| +43% | +$528K | 0.06% | 160 |
|
|
2020
Q2 | $1.39M | Hold |
110,999
| – | – | 0.05% | 161 |
|
|
2020
Q1 | $1.26M | Buy |
110,999
+4,160
| +4% | +$47.2K | 0.07% | 156 |
|
|
2019
Q4 | $1.4M | Buy |
106,839
+380
| +0.4% | +$4.98K | 0.06% | 150 |
|
|
2019
Q3 | $959K | Buy |
106,459
+8,200
| +8% | +$73.9K | 0.05% | 156 |
|
|
2019
Q2 | $969K | Sell |
98,259
-10,420
| -10% | -$103K | 0.05% | 164 |
|
|
2019
Q1 | $1.1M | Buy |
+108,679
| New | +$1.1M | 0.06% | 169 |
|